Skip to main content

Table 3 Schedule of enrolment and assessment

From: The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial

 

Baseline

During chemotherapy (every cycle)

Follow-up after chemotherapy (month)

0

1–8

6

12

18

24

36

Enrolment

 Informed consent

√

      

 Eligibility

√

      

General assessment

 Age

√

      

 Sex

√

      

 Height

√

      

 Weight

√

√

     

 Body surface area

√

      

 Surgical approach

√

      

 Chemotherapy regimen

√

      

 Chemotherapy strategy

√

      

 Pathological stage

√

      

 Molecular subtype

√

      

 ECOG PS

√

√

√

√

√

√

√

 EORTC QLQ-C30

√

√

     

 EORTC QLQ-BR23

√

√

     

 TCM constitution

√

√

     

 Chest CT

√

  

√

 

√

√

 *Breast MRI

√

  

√

 

√

√

 Serum tumour biomarkers

√

√

√

√

√

√

√

Key evaluation

 Blood routine test

√

At least once per week

√

√

√

√

√

Safety examination

 Urine routine test

√

√

√

√

√

√

√

 Liver function (ALT, AST, ALP, TBIL, GGT, etc.)

√

√

√

√

√

√

√

 Kidney function (CR, BUN, SCR, UA, etc.)

√

√

√

√

√

√

√

 Electrocardiogram

√

√

√

√

√

√

√

 Adverse events

 

√

√

√

√

√

√

Data evaluation

 Audit medical records

 

√

√

√

√

√

√

 Ombudsman reviews medical records

 

√

√

√

√

√

√

 Outcome measures

 

√

√

√

√

√

√

  1. *MRI assessments were conditionally performed according to the patient’s disease status